Señales en vivo de 600568.SS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 22:39):

Zhongzhu Healthcare Holding Co.,Ltd constructs and develops real estate properties in China. It also produces ophthalmic drugs; researches and develops natural botanical drugs...

Stats
Volumen de hoy	3.29M
Volumen promedio	6.55M
Capitalización de mercado	2.93B
EPS	CNY-0.108 ( 2023-06-30 )
Próxima fecha de ganancias	( CNY0 ) 2024-05-08
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-8.65
ATR14	CNY0.00600 (0.41%)

Volumen Correlación

Largo: 0.06 (neutral)

Corto: 0.00 (neutral)

Signal:(55.665) Neutral

Zhongzhu Healthcare Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Zhongzhu Healthcare Correlación - Moneda/Commodity

0.71
( moderate )

0.36
( neutral )

0.00
( neutral )

-0.94
( very strong negative )

-0.11
( neutral )

Zhongzhu Healthcare Finanzas

Annual	2023
Ingresos:	CNY580.06M
Beneficio Bruto:	CNY51.08M (8.81 %)
EPS:	CNY-0.170

FY	2023
Ingresos:	CNY580.06M
Beneficio Bruto:	CNY51.08M (8.81 %)
EPS:	CNY-0.170

FY	2022
Ingresos:	CNY505.97M
Beneficio Bruto:	CNY127.46M (25.19 %)
EPS:	CNY-0.400

FY	2021
Ingresos:	CNY581.06M
Beneficio Bruto:	CNY166.24M (28.61 %)
EPS:	CNY-0.105

Financial Reports:

No articles found.

Zhongzhu Healthcare

Zhongzhu Healthcare Holding Co.,Ltd constructs and develops real estate properties in China. It also produces ophthalmic drugs; researches and develops natural botanical drugs. In addition, it researches and develops drugs, such as recombinant human endostatin adenovirus injection, which is an anticancer gene therapy; Genistein capsule for the treatment of postmenopausal osteoporosis; and motherwort that is primarily a gynecological drug. Further, the company offers medical instruments, including radiation therapy, hyperthermia, phototherapy, and ultrasound diagnosis, as well as develops imaging breast tumor detection systems. Additionally, it offers medical services. The company was formerly known as Zhongzhu Holding Co., Ltd. and changed its name to Zhongzhu Healthcare Holding Co.,Ltd in June 2016. Zhongzhu Healthcare Holding Co.,Ltd was founded in 1970 and is headquartered in Qianjiang, China.